Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos


The cholesterol benefits of bempedoic acid plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported.At the National Lipid Association (NLA) Scientific Sessions, researchers presented three substudies of the CLEAR trials that evaluated the efficacy and safety of bempedoic acid (Nexletol, Esperion